Şunu aradınız:: risperidongroepen (Hollandaca - İngilizce)

in een 8 weken durende, placebogecontroleerde studie met vier vaste doseringen van risperidon (2, 6, 10 en 16 mg/ dag, tweemaal daags), hadden alle vier de risperidongroepen betere resultaten op de totaalscore van de positive and negative syndrome scale (panss) dan placebo.
in an 8- week, placebo-controlled trial involving four fixed doses of risperidone (2, 6, 10, and 16 mg/ day, administered twice daily), all four risperidone groups were superior to placebo on the positive and negative syndrome scale (panss) total score.